A Study of LY2608204 in Patients With Type 2 Diabetes

NCT01247363 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: LY2608204

Sponsor

Eli Lilly and Company